Letter: paradoxical skin eruptions during anti-TNF-α treatment of Crohn's disease

Aliment Pharmacol Ther. 2019 May;49(10):1369-1370. doi: 10.1111/apt.15244.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adalimumab
  • Crohn Disease*
  • Humans
  • Inflammatory Bowel Diseases*
  • Infliximab
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab